With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Generation of a novel oncolytic virus for treatment of pediatric brain tumors.||The Ohio State University / Balveen Kaur, PhD||Young Investigator Grants||2007||Ohio|
|The Identification of Neuroblastoma Cancer Stem Cells.||Stanford University / Robert Cho||Young Investigator Grants||2007||California|
|Developing an accurate genetic model for rhabdomyosarcoma therapy||Children's Research Institute / Dawn Chandler, PhD||Young Investigator Grants||2007||District of Columbia|
|The Role of Inhibition of Apoptosis by C/EBPalpha and C/EBPalpha oncoproteins in AML.||The Johns Hopkins University School of Medicine / Ido Paz-Priel, MD||Young Investigator Grants||2007||Maryland|
|Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma||The Pennsylvania State University / Ken Lucas, MD||Innovation Grants||2006||Pennsylvania|
|Modeling osteosarcoma to identify novel therapeutic targets.||Stanford University / Julien Sage||Young Investigator Grants||2006||California|
|Anti-Angiogenic Effects of BAI Proteins in Neuroblastoma||Children's Hospital of Philadelphia / Naomi Balamuth, MD||Young Investigator Grants||2006||Pennsylvania|
|Research Institute at Nationwide Children's Hospital / Mary Beth Ross, MD/PhD||Young Investigator Grants||2006||Ohio|
|Pax3-FKHR targets that enable bypass of cellular senescence in rhabdomyosarcoma.||Duke University Medical Center / Corinne Mary Linardic, MD, PhD||Young Investigator Grants||2006||North Carolina|
|Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture||Children's Hospital Los Angeles / Theresa Harned, MD||Young Investigator Grants||2006||California|